[Therapy of obstructive respiratory tract diseases. V: Mediator antagonists].
Ukena
D
D
Abteilung Pneumonologie, Medizinische Universitätsklinik Homburg/Saar.
Schlimmer
P
P
Vogt
J
J
Sybrecht
G W
GW
D000209:Acute-Phase Proteins / Q000037:antagonists & inhibitors*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000517:prevention & control*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000517:prevention & control*
D000209:Acute-Phase Proteins; D000893:Anti-Inflammatory Agents
Die Therapie obstruktiver Atemwegserkrankungen. Teil V: Mediatorantagonisten.